Periventricular heterotopia (PVH) is a congenital malformation of human cerebral cortex frequently associated with Filamin-A (FLN-A) mutations but the pathogenetic mechanisms remain unclear. Here, we show that the MEKK4 (MAP3K4) pathway is involved in Fln-A regulation and PVH formation. MEKK4 2/2 mice developed PVH associated with breaches in the neuroependymal lining which were largely comprised of neurons that failed to reach the cortical plate. RNA interference (RNAi) targeting MEKK4 also impaired neuronal migration. Expression of Fln was elevated in MEKK4 2/2 forebrain, most notably near sites of failed neuronal migration. Importantly, recombinant MKK4 protein precipitated a complex containing MEKK4 and Fln-A, and MKK4 mediated signaling between MEKK4 and Fln-A, suggesting that MKK4 may bridge these molecules during development. Finally, we showed that wild-type FLN-A overexpression inhibited neuronal migration. Collectively, our results demonstrate a link between MEKK4 and Fln-A that impacts neuronal migration initiation and provides insight into the pathogenesis of human PVH.
Introduction
Cerebral cortical development is a dynamic process that requires complex but precise coordination of cell proliferation, death, migration, and differentiation (Marin and Rubenstein, 2003; Rakic, 1988b) . Cortical malformations are often associated with mutations in genes that regulate each of these processes (Bielas et al., 2004; Haydar et al., 1999; Rakic, 1988a; Walsh, 1999) . Mitogen-activated protein kinases (MAPKs) are intracellular signal transduction molecules expressed in all eukaryotic cells that modulate these basic cellular events by responding to context-dependent extracellular signals (Morrison and Davis, 2003) . MAPKs are activated via signaling cascades involving MAPK kinases (MAP2Ks) that are in turn activated by MAPK kinase kinases (MAP3Ks). There are five major subgroups of MAPKs, namely ERK1/2, JNK, p38, ERK5, and ERK7 . The c-Jun NH 2 -terminal kinase (JNK) subgroup of MAPKs has been reported to affect region-specific cell death during early CNS development (Kuan et al., 2000) . More recently, JNK was shown to regulate cytoskeletal movement and cell migration by maintaining microtubule stability (Chang et al., 2003; Huang et al., 2003) . JNK binds and phosphorylates the microtubule associated protein, doublecortin (DCX) in growth cones of migrating neurons (Gdalyahu et al., 2004) , and overexpression of either dominant-negative JNK or MUK (a mixed lineage kinase and regulator of JNK activity) can impede radial neuronal migration (Hirai et al., 2002; Hirai et al., 2005; Kawauchi et al., 2003) . One of the MAP2Ks that activates JNK, MKK4 (also known as SEK1), can interact with Filamin-A (FLN-A), an actin-binding protein essential for cytoskeletal rearrangement and cell locomotion (Marti et al., 1997; Stossel et al., 2001 ). DCX and FLN-A mutations in human cause subcortical band and periventricular nodular heterotopias, respectively Gleeson et al., 1998) . Thus, JNK or its upstream regulators may be involved in the pathogenesis of these human disorders. How this pathway is regulated during neural development remains poorly understood.
MEKK4 (MTK1 in human) is one of w17 MAP3Ks cloned from mammalian cells that affects the activity of downstream MAP2Ks and MAPKs including JNK and p38 (Gerwins et al., 1997; Takekawa et al., 2005) . MEKK4 activity is stimulated by growth factors (e.g., EGF), inflammatory cytokines (e.g., angiotensin II), and environmental stress (e.g., MMS, UV and g irradiation; Abell et al., 2005; Derbyshire et al., 2005; Fanger et al., 1997; Gerwins et al., 1997) . Mice deficient in MEKK4 or possessing kinase-dead MEKK4 (MEKK4 K1361R ) develop CNS phenotypes, including severe neural tube closure defects and massive neuroepithelial apoptosis (Abell et al., 2005; Chi et al., 2005) . These mice exhibited reduced MKK4/SEK1 or MKK3/6 activity in the developing neuroepithelium but no detectable changes in JNK activity. The activity of p38, however, was altered in MEKK4 K1361R fibroblasts and affected downstream targets that possibly contributed to actin cytoskeletal breakdown. Thus, MEKK4 activity may be necessary for the integrity and rearrangement of the actin cytoskeleton (Abell et al., 2005; Yuzyuk and Amberg, 2003) . Notably, MEKK4 2/2 mice frequently develop PVH that manifest as cell accumulations lining and protruding into the lateral ventricles (Chi et al., 2005) . This suggests that MEKK4 may be required for cytoskeletal stability or integrity of the ventricular surface lining the developing forebrain (FB) which could influence neuronal migration away from the proliferative zone (PZ). Because a role for MEKK4 in developing FB is unknown, we hypothesized that MEKK4 regulates migration within and/or away from the cortical PZ by regulating key modulators of the actin cytoskeleton suspected to be essential during this process.
Here, we show that MEKK4 is expressed in embryonic mouse and human FB. PVH in MEKK4 2/2 mice arise from breaches in the ventricular surface lining and are largely comprised of postmitotic neurons. Cells within PVH fail to leave the VZ surface and migrate into the CP. Likewise; in utero electroporation of short interference RNA (siRNA) against MEKK4 impairs neuronal migration. Surprisingly, MEKK4 suppression results in abnormally high Fln-A expression and phosphorylation at Ser 2152 , a residue implicated in Fln-A cleavage and modulation of actin dynamics. We show that MKK4/SEK1 can interact with and mediate signaling between MEKK4 and Fln-A. Lastly, overexpression of FLN-A can inhibit neuronal migration. Together, our results indicate that MEKK4 contributes to the integrity of the VZ surface, regulates the amount of Fln, and mediates cell migration during FB development.
Results

MEKK4 Is Expressed in Progenitors and Neurons in Fetal and Adult Murine and Human Forebrain
MTK1 mRNA is ubiquitously expressed in fetal and adult CNS (Chan-Hui and Weaver, 1998; Takekawa et al., 1997) , although its expression pattern in developing FB has not been well characterized. In vitro studies have localized MEKK4 to the cytoplasm and in perinuclear vesicles (Gerwins et al., 1997; Halfter et al., 2005; Takekawa and Saito, 1998) . MEKK4 expression during mouse development was recently reported to be enriched throughout the entire neural tube as early as embryonic day (E) 8.5 (Abell et al., 2005; Chi et al., 2005) . To better localize MEKK4 signal in both developing and adult FB, we probed E16.5 and adult FB sections using in situ hybridization. MEKK4 expression in the embryo spanned the telencephalic wall (see Figure S1A in the Supplemental Data available with this article online) as well as all neocortical lamina of the adult FB (Figures S1B and S1C). Next, we performed western blot analysis to determine whether MEKK4 protein is expressed in developing human FB. We found that MEKK4 was expressed in human fetal FB during peak ages of neurogenesis and migration ( Figure S1D ). These data indicate that MEKK4 is expressed in neural progenitors and may play multiple roles throughout development and adulthood.
MEKK4
2/2 Mice Develop PVH Largely Comprised of Differentiated Neurons MEKK4 mutation results in highly penetrant neural tube defects and w50% of MEKK4 2/2 mice exhibited cranial exencephaly (Chi et al., 2005) . Among these affected mice, w70% display highly degenerated FB (''small FB'') due to massive apoptosis beginning wE9.5-10.5, while w30% display relatively normal size to slightly enlarged FB (''big FB'') compared to MEKK4 +/+ or +/2 mice (Chi et al., 2005) . Big FB MEKK4 mutants exhibited bilateral PVH that were characterized by focal disruptions of the VZ/SVZ and cell expansion into the ventricular space ( Figure 1A ). The intermediate zone (IZ) was typically thinner than controls. Remarkably, a relatively organized cortical plate (CP) overlay PVHs, although we periodically observed subpial ectopias (Figures 1A and 1B) and polymicrogyria ( Figure 1C ). It was also not uncommon to observe an overall decrease in CP thickness in big FB mutants ( Figures 1E and 1H ). PVH and ectopias were present in small FB phenotype as well (see below). In both phenotypes, disruptions of the VZ surface were more prevalent than ectopias. These observations suggest that despite a dramatic difference in size and morphology, both small and big FB MEKK4 mutants may share common molecular mechanisms that contribute to the disruptions of the ventricular and pial surfaces.
To determine the cellular composition of PVHs, we immunostained E18.5 FB with glial (GLAST) and neuronal (TUJ1) markers. PVHs weakly expressed GLAST ( Figure 1D ) but showed strong TUJ1 expression in both phenotypes ( Figures 1E and 1F ). Ectopias in small FB phenotype also expressed TUJ1 ( Figure 1G ) and Tbr1 ( Figure 1G 0 ), a transcription factor expressed by earlyborn glutamatergic cortical progenitors soon after differentiation and strongly expressed by layer 6 cells (Hevner et al., 2001 ). Tbr1 immunostaining in big FB phenotypes revealed that PVHs contained many intensely labeled Tbr1 + cells, suggesting many cells failed to reach layer 6 ( Figure 1H ). In addition to large PVH, we found Tbr1 + cells within ''normal'' areas of the VZ (where Tbr1 is normally absent) in both big ( Figure 1I ) and small FB (see below) phenotypes. These results suggest that small or widespread disruptions of the VZ surface in MEKK4 mutants may result in ectopic differentiation and/or inhibited migration of cortical neurons.
Failure of BrdU-Positive Cells to Leave the Ventricular Surface and PVH in MEKK4
2/2 Embryos The presence of PVH suggests that some cells are unable to migrate away from the VZ in MEKK4 2/2 FB. To test this, we exposed mice to bromodeoxyuridine (BrdU), which is incorporated into cells during S phase and examined the fates of BrdU + cells. Short exposure (1 hr) at E14.5 revealed comparable levels of S phase cells along the VZ of MEKK4 2/2 and MEKK4 +/+ mice (data not shown). Longer exposure (96 hr) at E18.5 in MEKK4 2/2 mice with big FB showed heavily labeled BrdU + cells within PVH ( Figure 2A ). BrdU + cells within PVH were TUJ1 + , indicating that these neurons failed to migrate away from the PVH (Figure 2A ). Consistent with these findings, short exposure (1 hr) of BrdU to E18.5 mice with big FB revealed that PVH were largely BrdU 2 (data not shown), suggesting that PVH are largely differentiated structures. Additionally, after 96 hr, we observed many heavily labeled BrdU + cells at the VZ surface in MEKK4 2/2 with small FB phenotype compared to MEKK4 +/+ mice ( Figure 2B ). These cells were located in abnormally TUJ1 + regions of the VZ (data not shown). Thus, Tbr1 immunostaining ( Figure 1) FB have a marked defect in their migratory capacity to exit the VZ surface. While the most severe defects were largely restricted to areas of VZ surface disruption, we cannot rule out more subtle migration defects that may affect nonheterotopic regions of MEKK4 2/2 FB.
In Vitro and In Vivo RNAi-Mediated Knockdown of MEKK4 Deleting the MEKK4 gene on a pure C57BL/6 mouse background caused neurulation defects wE9.0 that spanned the FB and hindbrain neuroepithelium (Chi et al., 2005) . PVH formation and subsequent migration defects could be secondary to failure of the neural tube to fuse properly. To circumvent this confounding issue, we designed siRNA against MEKK4 mRNA to assess whether depletion of MEKK4 in normal mouse FB neuroepithelium affected cell migration. We screened for effective siRNA constructs using the mU6pro vector (Yu et al., 2002) Figure S2A ). Western blot analysis confirmed the knockdown of both FLAG-MEKK4 ( Figure S2B ) and endogenous MEKK4 (Figure S2C ). In addition, we found that 48 hr post-in utero electroporation of E14.5 FB, siRNA#555 dramatically reduced MEKK4 mRNA compared to the contralateral hemisphere or siRNA#555 SCR ( Figure S2D ). Thus, siRNA#555 can be used to knockdown MEKK4 expression both in vitro and in vivo. 
MEKK4 RNAi Disrupts the Migration of Neocortical Progenitors
We hypothesized that knocking down MEKK4 in vivo might inhibit cell migration in the developing FB. To test this, we used in utero electroporation to deliver a 3:1 mixture of MEKK4 siRNA to RFP. Because the siRNA-containing mU6pro vector does not express a reporter gene, we performed control experiments which showed that coelectroporation of RFP and GFP results in w90% cotransfection (data not shown) which was similar to other reports (Bai et al., 2003) . We electroporated E14.5 FB with RFP alone (n = 7), siRNA control (siR-NA#555 4pt [n = 2], or siRNA#555 SCR [n = 2]) plus RFP, or siRNA#555 and RFP (n = 7) and analyzed the fates of RFP + cells at P0. In controls, we found that the majority of RFP + cells were located within the CP ( Figure 3A ). In contrast, electroporation of siRNA#555 resulted in dramatically more RFP + cells within the corpus callosum (CC) and PZ and considerably fewer cells within the CP ( Figure 3A) . In one E15.5 dam, we electroporated siR-NA#555 SCR plus GFP into the left hemisphere and siRNA#555 plus RFP into the right hemisphere. Analysis at P0 revealed that the majority of RFP + cells failed to enter the CP compared to GFP + cells ( Figure 3B ). Quantification of RFP + somas throughout the FB showed that compared to controls, siRNA#555 resulted in w50% fewer cells reaching the CP and significantly more cells within the CC (w40% compared to w3% in controls) and PZ (w3% compared to w0.5% in controls; Figure 3C ). Inhibited migration by siRNA#555 was also observed after 72 hr (data not shown). In additional experiments, we exposed electroporated mice to BrdU 24 hr after electroporation (E15.5). We reasoned that at electroporated sites, since nearly all cells in the VZ would be RFP + , exposure to BrdU should label a significant percentage of RFP + cells. Analysis of BrdU and RFP at P0, after transfection with MEKK4 siRNA#555, revealed many RFP + /BrdU + cells in the CC compared to control (RFP alone) where most RFP + /BrdU + cells were located in the CP ( Figure S3 ). In siRNA#555-transfected brains, there appeared to be fewer BrdU+ cells in the CP region located above the heterotopia compared to adjacent neocortical areas or comparable regions of the opposite hemisphere ( Figure 3D ). In separate experiments, we tested whether some cells arrested at the VZ surface were neuronal by coelectroporating siRNA#555 with Ta1 Venus-GFP (a neuronal-specific promoter [Gloster et al., 1999] ). Six days after coelectroporation, many GFP + cells were stuck at the VZ surface in siRNA#555-transfected brains compared to control ( Figure 3E ). Although examination of radial glial morphology at a range of postelectroporation time points (e.g., 24, 72, and 96 hr) did not show grossly affected morphology (data not shown), we cannot rule out that siRNA#555 resulted in subtle radial glial defects affecting migration. In any event, these results suggest that MEKK4 is important for neuronal progenitor cells to migrate away from both the VZ and IZ.
Deleting MEKK4 in mice results in enhanced apoptosis wE8.5-9.0 and frequent FB degeneration (Chi et al., 2005) . We therefore hypothesized that MEKK4 RNAi may enhance cell death if MEKK4 additionally plays an antiapoptotic role. Analysis of the morphology of RFP + cells at P0 in brains transfected with siRNA#555 revealed many unhealthy, apoptotic profiles in the CP, CC, and VZ/SVZ (data not shown). We stained for apoptotic nuclei using the TUNEL method and found that compared to RFP alone (or 555 SCR ), siRNA#555 resulted in many TUNEL + /RFP + cells in the VZ/SVZ, CC, and CP (Figure S4) . Together, the results suggest that in addition to playing a role in neuronal migration, MEKK4 may also have an antiapoptotic function that ensures the survival of proliferating, migrating, and differentiating neurons.
Compromised Integrity of the VZ Surface May Predispose MEKK4 Mutants to PVH Radial glial endfeet form an adhesive lining at both the VZ and pial surface (Levitt and Rakic, 1980) , and defects in these structures could predispose mice to PVH. Integrins are involved in the assembly of the basal lamina and radial glial endfeet anchoring. Defects in integrin receptors, integrin-linked kinases, as well as dystroglycan complexes have been implicated in the pathogenesis of breeches at the outer cortical surface (Moore et al., 2002; Niewmierzycka et al., 2005; Schmid et al., 2004) . We therefore examined whether there were extracellular matrix abnormalities in MEKK4 2/2 FB by probing for laminin, a glycoprotein that binds cell membranes via integrin receptors and the dystroglycan complex (Campos et al., 2004; Powell and Kleinman, 1997) . Consistent with previous studies, laminin was detected in the pia, blood vessels, and along the VZ surface of MEKK4 +/+ FB ( Figure 4A ). Coimmunostaining with RC2, a radial glial marker, revealed laminin and RC2-labeled radial glial endfeet at the VZ surface ( Figure 4A ). In contrast, we found areas of severe discontinuity in laminin staining at both the VZ and pial surface of MEKK4 2/2 small (Figures 4B and 4D) and big FB ( Figure 4C ) phenotypes. The morphology and organization of RC2 + fibers was markedly disrupted at sites where laminin was disrupted ( Figure 4B ). Remarkably, RC2
+ fibers adjacent to PVH appeared to navigate around PVH areas to establish a normal pattern of radial glial scaffolding in the upper regions of the CP even when the underlying areas were severely disrupted ( Figure S5) . Additionally, at sites of ectopias, RC2 + fibers were observed extending beyond the pia mater ( Figure 4D ). These observations might explain how a relatively organized CP forms over PVHs. Furthermore, staining of MEKK4 2/2 big FB with the F-actin binding probe, phalloidin, appeared to show disruptions of the adherens junctions complexes along the VZ surface ( Figure 4E ). Notably, these disruptions also showed invasion of nuclei into the ventricular space ( Figure 4E ). Together, these results suggest that the loss of MEKK4 may lead to defects in the VZ surface integrity that promote the formation of PVH.
Elevated Fln Expression in MEKK4
2/2 Mice Because bilateral PVH are common in patients with lossof-function FLN-A mutations Sheen et al., 2001) In utero electroporation of fetuses at E14.5, exposure of dams to BrdU at E15.5, and analysis at P0. Example of a brain electroporated with siRNA#555 shows a heterotopia (arrows) beneath the CP (ipsilateral) that contained many BrdU + cells (arrows). In the ipsilateral area of CP (corresponding to the asterisk in lower panel), reduced BrdU immunostaining is observed over the heterotopia compared to the adjacent CP or opposite hemisphere (contralateral). Bar = 100 mm. (E) Electroporation of pTa1 Venus-GFP alone (E 0 ) or with siRNA#555 (E 00 -E 0000 ) and immunostaining for GFP. (E 0 ) Electroporation of pTa1 Venus-GFP alone (2555) resulted in most GFP + cells reaching the cortical plane (not visible in picture) with their axonal projections (arrow). (E 00 ) Coelectroporation with siRNA#555 (+555) resulted in many GFP + cells at the VZ surface. (E 00 0 and E 00 00 ) Higher magnifications of the boxed areas in (E 00 ) revealed cell bodies that remained at the VZ surface (arrowheads).
are the two major isoforms expressed in the developing brain (Sheen et al., 2002) . To determine which isoform contributed to increased Fln in MEKK4 2/2 FB, we probed blots with Fln-A-and Fln-B-specific antibodies. We found that MEKK4-deficient FB showed increased Fln-A ( Figure 5B ) and Fln-B ( Figure 5A ). To determine where these changes occurred in MEKK4
2/2 FB, we immunostained E17.5 FB with phospho-Fln-A, Fln-A, and Fln-B antibodies. In controls, all Fln antibodies showed comparable immunostaining patterns with the strongest signal located in the IZ and CP ( Figures 5D, 5E , and S6). Blood vessel staining was also detected with some of the Fln antibodies (Figures 5E and S6) . In contrast to MEKK4 +/+ or +/2 mice, we found that phosphorylated Fln-A was expressed within PVH of MEKK4 2/2 FB ( Figure 5D ) that were also positive for Fln-A and Fln-B ( Figure S6 ). In addition, we observed cells along the VZ surface (particularly at sites where the integrity of the VZ surface appeared disrupted) and in the IZ (data not shown) that appeared to express abnormally high levels of Fln-A and phospho-Fln-A compared to MEKK4 +/+ (Figures 5E-5H ). Double immunostaining with Tbr1 confirmed that these highly Fln-A-positive cells were neuronal (Figures 5F-5H) .
Overexpression of Fln-A in mouse FB can restrict migrating cell polarity to a more radial orientation as cells pass through the IZ (Nagano et al., 2004) . Similarly, closer analysis of TUJ1 immunoreactivity in MEKK4-deficient FB (big or small phenotype) in nonheterotopic regions showed many radially oriented TUJ1 + processes entering the IZ compared to control ( Figure S7 ). Together, these results suggest that MEKK4 deletion may lead to enhanced or dysregulated Fln expression that subsequently impairs the migration and morphology of many neocortical progenitors.
GST-SEK1 Can Precipitate MEKK4 and Fln-A MKK4/SEK1 is a MAP2K reported to bind FLN-A in melanoma cells and serves as one substrate for MEKK4 (Gerwins et al., 1997; Marti et al., 1997) . Therefore, MKK4/SEK1 could serve as a mechanism that brings MEKK4 and Fln-A together during neocortical development. To test this, we incubated COS-7 or E17.5 FB cell lysates with GST-MKK4/SEK1 and probed blots for endogenous MEKK4 and Fln-A. Compared to glutathione-agarose beads or beads coated with GST, GST-MKK4/SEK1 precipitated endogenous MEKK4 and Fln-A ( Figure 6A ) from the same extracts. These results suggest that MEKK4 may be part of an intracellular complex with Fln-A via MKK4/SEK1. During development, this signaling pathway could play a role in coordinating neuronal migration.
Knockdown of MEKK4 Enhances Fln-A Phosphorylation on Ser 2152 via MKK4/SEK1 FLN-A phosphorylation on Ser 2152 has been implicated in providing resistance to FLN-A cleavage and mediating actin cytoskeletal assembly (Garcia et al., 2006; Vadlamudi et al., 2002; Woo et al., 2004) . To test whether MEKK4 RNAi can affect Fln-A phosphorylation, protein extracts were collected from NIH3T3 cells that were either mock or siRNA#555 transfected and cultured for 96 hr. Western blot analysis revealed enhanced phospho-Fln-A relative to total Fln-A signal in siRNA#555-transfected compared to control cultures ( Figures 6B  and 6C ). Therefore, MEKK4 suppression by RNAi can lead to increased Fln-A phosphorylation at Ser 2152 . Next, we tested whether the increased Fln-A phosphorylation at Ser 2152 induced by MEKK4 RNAi could be blocked by cotransfection with a dominant-negative form of MKK4/SEK1 (dnSEK1). We found that siRNA#555 increased Fln-A phosphorylation as early as 24 hr posttransfection; however, when cotransfected with + fibers into the ectopia (small arrowheads). (E) Phalloidin-labeling of F-actin (green) revealed defects in the continuity of the adherens junctions complexes (aj) along the VZ surface in MEKK4 2/2 big FB (arrows in middle, right panels) compared to +/+. Nuclei (blue) appeared to be invading the ventricular space at these disrupted sites (arrows). Bars (mm) representing middle (and left) panel = 20 and right = 50. dnMKK4/SEK1, the phosphorylation of Fln-A was decreased ( Figures 6D and 6E) . These results suggest that in the absence of MEKK4, phosphorylation of Fln-A at Ser 2152 depends on MKK4/SEK1 signaling and that under normal conditions, MEKK4 could influence Fln-A phosphorylation.
Overexpression of Wild-Type FLN-A Can Disrupt Radial Migration
Increased Fln-A can inhibit cell migration in nonneuronal cells and alter the morphology of migrating neurons (Cunningham et al., 1992; Nagano et al., 2004) . Loss of MEKK4 resulted in increased Fln-A that was associated with regions of failed migration initiation. To test whether increased Fln-A can inhibit neuronal migration, we overexpressed a full-length human wild-type (WT) FLN-A with GFP and analyzed GFP + cell distribution within the CP and subplate (SP) after 96 hr. We found that WT FLN-A overexpression resulted in significantly fewer cells in upper CP and more cells in deeper CP and SP compared to control (GFP plus empty cDNA3.1 vector; Figures 7A  and 7B ). These data suggest that mutations leading to excessive Fln-A could impair neuronal migration.
Discussion
Malformations of human FB are often attributed to genes that regulate neuronal migration (Feng and Walsh, 2001; Rakic, 1988a) . Our data suggest a relationship between MEKK4 and Fln-A that not only influences migration initiation but also the integrity of the neuroependymal lining. Loss of MEKK4 dramatically disrupts the amount and phosphorylation of Fln-A, possibly contributing to the pathogenesis of PVH.
MEKK4 Expression in the Mammalian Brain
MEKK4 is highly expressed in the developing murine and human neural tube and persists throughout peak cortical neurogenesis into adulthood ( Figure S1 and Abell et al. [2005] , Chan-Hui and Weaver [1998] , Chi et al. [2005] ). Two splice variants have been detected from mouse brain cDNA, MEKK4a and MEKK4b (Gerwins et al., 1997) . MEKK4a differs from MEKK4b by an additional 52 amino acid sequence in the noncatalytic domain. The targeting strategies of both MEKK4 2/2 mice and siRNA would predictably result in deletion or reduction of both isoforms. Whether these two isoforms are differentially regulated in the developing or adult CNS is unknown. The widespread expression of MEKK4 in the CNS suggests its function may extend to other neural cell types and depend on local environmental stimuli.
Neuronal Migration Defects in MEKK4
2/2 and RNAi-Treated Brains With the exception of FLN-A and ARFGEF2, little is known about the molecular regulators of migration initiation in developing FB (Bielas et al., 2004; Marin and Rubenstein, 2003) . Our data suggest that MEKK4 is involved in this process. About 50% of MEKK4 2/2 mice developed bilateral PVHs that largely consisted of differentiated neurons (Figure 1) . Exposure of E14.5 MEKK4 2/2 mice (big or small FB) to BrdU and analysis at E18.5 revealed that cells within PVH failed to leave the VZ surface (Figure 2 ). SiRNA#555 produced heterotopias more frequently in the CC, although a significant percentage of neuronal progenitors remained at the VZ surface (Figure 3) . The full effect of siRNA may be delayed until endogenous MEKK4 is completely degraded and cells have exited the VZ/SVZ. Because of these temporal and spatial differences, if migrating cells use different mechanisms to exit the VZ than to exit the CC, an RNAi-mediated strategy may differentially disrupt the signaling pathways that govern each event. In the MEKK4 2/2 FB, the complete loss of MEKK4 may have the most severe effect on migrating cells at sites of VZ surface abnormalities, resulting in VZ surface arrest. Notably, these were sites associated with enhanced Fln-A expression ( Figure 5) . Additionally, the abnormal orientation of TUJ1 + fibers in the IZ of nonheterotopic regions of neocortex suggests that many MEKK4 2/2 cells may be prone to subtle defects in migration ( Figure S7 ). Since MEKK4-deficient neurons were arrested at both the VZ surface and beneath the CP, MEKK4 may be essential for both the initial and intermediate stages of migration.
JNKs can be activated by MEKK4, and JNK can phosphorylate DCX (Gdalyahu et al., 2004; Gerwins et al., 1997) . However, JNK activity was not altered in MEKK4 2/2 or MEKK4 K1361R CNS (Abell et al., 2005; Chi et al., 2005) , and we did not observe altered total or phospho-DCX by western blot (data not shown). Conceivably, insufficient MEKK4 signaling could transiently disrupt JNK signaling, in turn affecting DCX activity arresting cells beneath the CP. This would be consistent with the effects of DCX siRNA (Bai et al., 2003; Ramos et al., 2006) . Because MEKK4 2/2 mice display both affected migration and enhanced apoptosis (Figures 2 and 3 and Chi et al. [2005] ), we propose that the MEKK4 siRNAtreated brains reflect phenomena observed in mutants with both big and small FB phenotypes. Though enhanced apoptosis may be a due to an accumulated effect of RNAi, the data further support a prosurvival role for MEKK4 during development. Whether arrested cell migration leads to the onset of apoptosis in siRNA-transfected cells or vice versa is not clear. Although the degree to which the mechanisms underlying knockout and RNAi phenotypes are shared is unclear, taken together our data support a critical role for MEKK4 in cortical neuronal migration.
Abnormalities in the Neuroependymal Lining after MEKK4 Deficiency
The putative cause of most PVH is a loss of function of FLN-A resulting in arrested neurons at the VZ surface (Feng and Walsh, 2004) . Alternatively, PVH may arise from defects in cell adhesion or the extracellular matrix (ECM) lining the ventricular surface (Lu et al., 2006; Sheen et al., 2005) . MAPK signaling is activated by b-integrins and FLN-A (Campos et al., 2004; Scott et al., 2006) , suggesting that dysfunctional MAPK signaling could alter critical signaling cascades that maintain the strength of the VZ surface. Notably, a recent study suggests that FLN-A may span the plasma membrane and interact with integrins within the ECM (Bachmann et al., 2006) . Therefore, mutations that alter FLN-A expression or function could impact both migrating cells and the ECM lining the lateral ventricles. Consequently, it is not clear whether PVH arise from autonomous cell migration defects, nonautonomous effects on the neuroependymal lining, or both.
Here, we provide evidence in MEKK4-deficient mice for a breakdown of the VZ (and pial) surface revealed by disrupted laminin staining (which binds integrins) that was associated with disorganized radial glial endfeet (Figure 4) . Although not frequently observed, some siRNA#555-transfected brains at P0 did show pronounced disruption of the VZ surface at electroporated (A) Ten micrograms of GST-MKK4/SEK1 (GST-SEK1) was incubated in either w500 mg of COS-7 lysate or w1 mg E17.5 mouse FB lysate. As controls, equivalent amounts of COS-7 or FB lysates were incubated in glutathione-agarose beads (Beads) or beads preincubated in GST (GST-beads). One percent of lysates (1% input) were run for COS-7 or FB lysates. The upper blot was probed with anti-MEKK4 (CT) antibody and shows GST-MKK4/SEK1 precipitated endogenous MEKK4 in both COS-7 and FB lysate. Twenty micrograms of E15.5 MEKK4 2/2 FB lysate was run as a control. A doublet band is precipitated in both COS-7 and FB lysate with the upper band corresponding to MEKK4. The lower blot was probed using an anti-Fln-A antibody and showed that GST-MKK4/SEK1 also precipitated endogenous Fln-A from COS-7 and FB lysates. sites ( Figure S4C ). Irrespective of VZ integrity, neuronal precursors were clearly stuck at the VZ surface of RNAi-exposed mice ( Figure 3E ), suggesting a possible intercellular signaling defect between radial glia and affected neuronal precursors. The complete deletion of MEKK4 may cause more severe, but incompletely penetrant, effects on radial glial scaffolding at the VZ surface due to compensatory factors (Figure 4) .
Because enhanced apoptosis was observed in both MEKK4 knockout and siRNA, death of radial glia may also compromise the integrity of the VZ surface and affect adjacent radial glial morphology and migrating cells. MEKK4 has been shown to mediate the Wnt signaling pathway (Luo et al., 2003) , which when disrupted causes radial glial scaffolding defects (Zhou et al., 2004) . We found that radial glial abnormalities and Fln-A upregulation typically colocalized in MEKK4 2/2 FB. Although Fln-A overexpression (Figure 7) did not reveal gross defects in radial glia morphology or VZ surface integrity (data not shown), we cannot rule out subtle defects in these structures that impaired the migration process. Alternatively wild-type FLN-A overexpression may preferentially disrupt migrating neurons. In any event, proper MEKK4 signaling may be required at both the inner and outer cortical limits to maintain the integrity of the neuroependymal lining which when compromised allows cells to enter the ventricular space (or breach the pial lining) contributing to PVH pathogenesis. How these defects lead to impaired migration is unclear but is likely attributable to changes in molecules that normally regulate migration initiation.
Loss of MEKK4 Enhances Fln-A Expression and Phosphorylation
Fln-A is expressed in developing FB and regulates actin dynamics essential to cell motility (Lu et al., 2006; Nagano et al., 2002; Sheen et al., 2002; Stossel et al., 2001) . Consistent with other reports, we showed that Fln expression (including phosphorylated, A, and B isoforms) was low within wild-type VZ (with the exception of blood vessel and microglia staining consistent with a proposed role for FLN-A in blood vessel development [Kakita et al., 2002] ) and high in the IZ and CP ( Figures  5 and S6 ). In contrast, we observed elevated Fln-A, phospho-Fln-A, and Fln-B within MEKK4 2/2 FB. PVHs expressed high levels of Fln isoforms compared to control VZ, and ectopic sites (especially where the VZ surface was disrupted) displayed Tbr1
+ neurons with excessive Fln-A ( Figure 5 ). These results suggest that MEKK4 deletion causes ectopic increases in Fln-A and subsequent inhibition of neuronal migration. Whether or not increased Fln-A is also directly responsible for defects in the neuroependymal lining remains unclear.
Can MEKK4 influence Fln-A function? MAPK signaling complexes are connected by protein scaffolds within the cytoplasm which include Fln-A (Feng and Walsh, 2004; Morrison and Davis, 2003) . We show that MKK4/SEK1 may serve to bridge MEKK4 and Fln-A as both molecules precipitated from FB ( Figure 6 ). Further, MEKK4 siRNA enhanced Fln-A phosphorylation that was blocked by dnMKK4/SEK1. MKK4/SEK1 binds but does not appear to phosphorylate Fln-A in vitro (Marti et al., 1997) , although whether MKK4/SEK1 directly phosphorylates Fln-A at Ser 2152 in the brain is unknown. Thus under normal conditions, MEKK4-MKK4/SEK1 signaling may act to inhibit Fln-A phosphorylation via downstream targets. In the absence of MEKK4, these targets may overphosphorylate Fln-A at Ser 2152 . These data suggest that MEKK4 signaling could influence Fln-A phosphorylation and, as discussed below, alter its expression.
Consequence of Increased Fln-A on Neuronal Migration
Loss-of-function FLN-A is clearly associated with defective neuronal migration, but our findings are consistent with multiple lines of evidence that suggest excess Fln-A also affects migration. Nonneuronal studies have shown that migration depends on the intracellular concentration of FLN-A and that too little or too high FLN-A can impede cell migration (Cunningham et al., 1992) . Similarly, increased FLN-A binding to b-integrin can inhibit migrating cells (Calderwood et al., 2001) , and since both molecules are present along the VZ surface (Campos et al., 2004; Lu et al., 2006) , abnormally high Fln-A could increase Fln-A-b-integrin binding impairing migration away from the VZ surface.
Fln-A expression is controlled both genetically and molecularly. At the genetic level, mechanical force induction of b 1 -integrin receptors can selectively activate the p38 pathway and induce FLN-A transcription (D' Addario et al., 2002) . Notably, we also observed increased p38 phosphorylation after MEKK4 RNAi ( Figure S8 ). Why in vitro studies did not show increased total Fln-A like our mutants was puzzling and may reflect intrinsic differences between neurons and fibroblasts or require more time for significant Fln-A accumulation to occur.
Molecular studies have shown that Fln-A phosphorylation on Ser 2152 confers resistance to calpain cleavage and is required for p21-activated kinase-1-mediated actin cytoskeletal assembly (Garcia et al., 2006; Vadlamudi et al., 2002) . Enhanced Fln-A phosphorylation at Ser 2152 was observed in MEKK4 2/2 brains and after siRNA (Figures 5 and 6 ). Therefore, enhanced Ser 2152 phosphorylation may prevent Fln-A cleavage or degradation and result in Fln-A accumulation that subsequently affects actin dynamics during neuronal migration. Alternatively, FILIP (Fln-A-interacting protein) is a potent degrader of Fln-A and is expressed in developing FB. FILIP is thought to maintain a gradient of Fln-A such that expression is low in the VZ and higher toward the IZ and CP (Nagano et al., 2002; Sato and Nagano, 2005) . FILIP siRNA (which increases Fln-A) significantly altered the morphology of migrating neurons. Thus, future studies should examine whether FILIP activity is altered in MEKK4 2/2 mice or whether FILIP is itself regulated by MEKK4 (or other MAP3K pathways). In any event, mechanisms are in place in the cortical PZ to maintain low Fln-A (Sato and Nagano, 2005) . Overexpression of wild-type Fln-A was reported to affect the morphology of migrating neurons (Nagano et al., 2004) . Here, we add to that finding and show that wildtype FLN-A overexpression can delay migration into the CP (Figure 7 ). Our findings suggest that MEKK4 deficiency results in an overall increase in Fln-A. Cells with excessively high Fln-A may have impaired migration initiation, while those with moderately increased Fln-A may have milder defects, including arrested migration in the IZ and disrupted morphology. Therefore, mutations resulting in increased Fln-A may impair neuronal migration.
MEKK4 as a Candidate PVH Gene MEKK4-deficient and MEKK4 K1361R mice display a range of malformations including neural tube closure defects, skeletal anomalies, and body wall closure defects (omphalocoele; Abell et al. 2005; Chi et al., 2005) . Interestingly, similar abnormalities have been observed in humans with mutations in the FLN-A gene leading to FLN-A gain of function (Robertson et al., 2003; Zenker et al., 2004) . While the majority of PVH phenotypes are caused by X-linked loss-of-function FLN-A mutations Sheen et al., 2001) , there are many cases of PVH that are not due to FLN-A (Sheen et al., 2003a; Sheen et al., 2003b; Sheen et al., 2004) . Surprisingly, a recent report showed that mice lacking Fln-A do not develop PVH (Hart et al., 2006) . It has been hypothesized that in the absence of FLN-A, FLN-B can compensate, but this mechanism has not been well studied. Our data suggests that genetic mutations resulting in the overexpression or enhanced phosphorylation of FLN-A may also lead to PVH. Until recently, Fln-A was thought to localize intracellularly; however, it may have an unappreciated role on the outer cell surface and interact with ECM proteins (Bachmann et al., 2006) . Thus, the impact of MEKK4 deficiency on Fln-A could affect both neuronal migration and the ECM that stabilizes the neuroependymal lining. MEKK4 may therefore be considered a candidate autosomal gene underlying human PVH or contribute to the pathogenesis of PVH in the presence of FLN-A mutations. Exactly how MEKK4 and Fln-A maintain VZ surface integrity and regulate migration is the focus of future studies.
Experimental Procedures Mice
The generation of MEKK4-deficient mice on a C57BL/6 background was described previously (Chi et al., 2005) , while timed-pregnant C57BL/6 mice for in utero electroporation were purchased from Charles River Laboratories. Fetal stage was calculated from the day when a vaginal plug was observed (considered as E0.5), and confirmed by comparing the brain morphology to characterized embryonic structures (Kaufman, 1995) . All animal protocols were in accordance with Yale University IACUC guidelines.
Histology and Immunocytochemistry
Embryos and postnatal mice were fixed or perfused using Boiun's solution or 4% PFA. Brains were either cryoprotected, frozen over liquid N 2 and sectioned on a cryostat, or embedded in wax and sectioned on a microtome. Sections were stained with 0.1% thioninNissl solution or processed for immunostaining using standard procedures. Tissue for BrdU immunohistochemistry was pretreated for 15 min in 2 N HCl at 40 C and rinsed in 0.1 M sodium borate (pH 8.5). Primary antibodies included rat anti-BrdU (1:100; Accurate), mouse anti-TUJ1 (1:1000; Sigma), rabbit anti-Fln-A and mouse anti-Fln-A (mAb(4-4)) (1:200; this antibody was generated as previously described and detects both Fln-A and Fln-C (data not shown); however, FLN-C is not expressed in brain [Goetsch et al., 2005] ), and mouse anti-phospho-Fln-A(mAb(p2152Fln-A)) (1:200; see below for synthesis detail), rabbit anti-Fln-B (1:500; gift from S. Shapiro), rabbit anti-Laminin (1:50; Sigma), mouse anti-RC2 (1:2; Developmental Studies Hybridoma Bank), rabbit anti-Tbr1 (1:1000; Chemicon), rabbit anti-GFP (1:1000; Invitrogen), and guinea pig anti-GLAST (1:8000; Chemicon). Primary antibodies were labeled with appropriate fluorophore-conjugated secondary antibodies (Invitrogen). F-actin was labeled with Alexa Fluor 488 phalloidin (1:40; Invitrogen). Nuclei were stained with propidium iodide (1:2000; Sigma), TO-PRO-3 iodide (1:1000; Invitrogen), or 4 0 6-diamidino-2-phenylindole dihydrochloride (DAPI) (1:5,000; Sigma). All images were captured using a confocal LSM 510 NLO system or an Axioplan 2 microscope equipped with epifluorescence and an ApoTome module (Zeiss).
Production of Monoclonal Antibodies Specific for Phospho-2152Ser-FLN-A
The serine phosphorylated peptide CRAPp2152SVAN (Cys2150Arg-Ala-Pro-phosphoSer-Val-Ala-2155Asn) and the nonphosphorylated peptide CRAPSVAN were chemically synthesized by AnaSpec Inc. Each peptide was coupled to keyhole limpet hemocyanin (KLH) through the amino-terminal cysteine of the peptide, with m-maleimidobenzoyl-N-hydroxysuccinmide ester using a kit. Approximately 10 mg of peptides conjugated to KLH were immunized to BALB/c mice, and the hybridoma clones were produced as previously described . To screen antibodies specific for phospho-FLN-A by ELISA, recombinant hsFLN-A protein was used because about 60% of the purified FLN-A from insect cells was found to be phosphorylated (F.N. and T. Stossel, unpublished data). The purified FLN-A was treated with alkaline phosphatase (P-6774, Sigma) to dephosphorylate FLN-A and used as a negative-control antigen for ELISA. Hybridomas were cloned and adapted to serum-free media, and monoclonal antibodies were purified as previously described .
Construction of the FLAG-Tagged MEKK4 Expression Vector A cDNA clone containing the full-length MEKK4 reading frame (IMAGE, 5705378) was ordered from ATCC. A FLAG tag (DYKDDDDK) was inserted into the 5 0 end of the cDNA by PCR, and the entire construct was subcloned into the pcDNA3.1/MycHis(2) vector (Invitrogen). The DNA sequence was confirmed by automatic sequencing.
siRNA Design, Testing, and In Utero Electroporation We used the Ambion website (www.ambion.com) to screen siRNA sequences against the mouse MEKK4 gene (accession #: NM_011948). BLAST searches of selected sequences revealed no significant homology to other mammalian genes. Three different constructs were designed for insertion into the mU6pro vector (Yu Neuronet al., 2002 0 -TTTGAAGTCCACAGAAGCGAGAGTTC AAGAGACTCTCGCTTCTGTGGACTTTTTTT-3 0 ; reverse, 5 0 -CTAGAA AAAAAGTCCACAGAAGCGAGAGTCTCTTGAACTCTCGCTTCTGTG GACTT-3 0 ). Forward and reverse oligos were ordered from Yale University DNA Synthesis Laboratory, annealed, phosphorylated, and ligated into the mU6pro vector as described (Yu et al., 2002) .
To screen siRNA efficacy in vitro, NIH 3T3 cells (ATCC) were grown on poly-L-ornithine and laminin-coated glass coverslips and transfected using Lipofectamine 2000 (Invitrogen) with the following constructs: pCAGGSmRFP (gift from J. LoTurco), FLAG-MEKK4 (described above), and pmU6pro containing either siRNA#555, siRNA#555 4pt , or siRNA#555 SCR constructs. Cells were fixed with 4% PFA 72 hr posttransfection, washed, immunostained with an anti-FLAG (BioM2) antibody (1:4000; Sigma). To analyze MEKK4 siRNA in vivo, we used in utero electroporation. Briefly, C57BL/6 mice, 14.5 or 15.5 days into gestation, were anesthesized by injection of ketamine (37 mg/kg)/xylazine (1.9 mg/kg). The uterine horns were exposed, and 1-3 ml constructs (3:1 ratio of mU6pro:RFP)/0.025% Fast-Green was microinjected through the uterus into the lateral ventricles of the cerebral cortex by pulled glass capillaries. Electroporation was achieved by discharging 40V across the cortex in five-pulse series spaced 50 ms apart using a BTX ECM 830 Square Wave Electroporator. Dams were sutured and placed on heating pads until they awoke. Some dams received BrdU (50mg/kg i.p.) 24 hr postelectroporation. Electroporated pups were transcardially perfused at P0 with 4%PFA. Brains were removed, fixed overnight in 4%PFA, cryoprotected, and frozen over liquid N 2 .
Quantification of Electroporated Cells
The distribution of RFP + cells in electroporated brains was examined on a Zeiss Axioskop 40 epifluorescent microscope and analyzed using Neurolucida (MicroBrightField Inc.). Brains were cryosectioned (20 mm) and stained with 4 0 -6-diamidino-2-phenylindole (DAPI; Sigma) to trace contours of the PZ, CC, and CP on each section (w6 sections/brain). The soma locations of all RFP + cells/section were marked and the data was expressed as the percentage of the total number of RFP + cells per contour/total number of RFP + cells per section. Statistical analysis was performed using ANOVA with p < 0.05 considered significant. Error bars are the standard error of the mean.
Western Blot and GST-SEK1 Pulldown Assay Protein extracts prepared from mouse and human fetal FB, NIH3T3, or COS-7 cell lysates were solubilized in ice-cold 13 lysis buffer (Cell Signaling) supplemented with a protease inhibitor cocktail (1:100; Sigma) and phosphatase inhibitor cocktail-1 (1:100; Sigma) and 1 mM PMSF. K562 cell lysate was purchased from Upstate Biotechnology. Lysates were run at 30 mA on Tris-HCl gels (Bio-Rad) and transferred onto PVDF (Bio-Rad) at 300 mA for 2 hr. For GST-pulldown assays, GST-SEK1 (K129R) (agarose-conjugated; Calbiochem), glutathione-agarose beads (Sigma), or glutathione-agarose beads preincubated for 1 hr with 100 mg/ml GST (Sigma) were added to w500 mg COS-7 or 1 mg E17.5 FB lysate overnight at 4 C, washed four to five times in lysis buffer, eluted, and separated by SDS-PAGE. For the NIH3T3 experiment involving dnMKK4/SEK1, cells were transfected with pAd.RSV-MKK4(DN) (Cell Biolabs, Inc.). Immunoblot analyses were performed using rabbit anti-MEKK4 (C terminus antibody; 1:5000) (gift from R. Vaillancourt), anti-Fln-A* (Cell Signaling; *in this study considered a total Fln antibody since it may crossreact with FLN-B and -C), anti-FLN-A (1:2000), anti-phospho-Fln-A (Ser 2152 ) (1:1000; Cell Signaling), anti-Fln-B (1:500; gift from S. Shapiro), anti-p38 (1:1000; Cell Signaling), anti-phosphop38 (1:2000; Chemicon), and mouse anti-GFP (1:5000; BD Biosciences), anti-b-actin (1:10,000; Sigma), anti-GAPDH (1:10,000; Abcam), and anti-FLAG M2 (1:5000; Sigma) antibodies. Appropriate HRP-conjugated secondary antibodies (1:10,000; Bio-Rad) were detected by chemiluminescence (Amersham Biosciences). To determine band intensity, blots were scanned at 1200 ppi, imported, and analyzed in Adobe Photoshop 7.0.
Overexpression of FLN-A In Vivo
Plasmids expressing WT -FLN-A (pcDNA3.1-myc-FLN-a) and GFP or GFP and pcDNA3.1 (empty vector) were electroporated at E14.5 and mice sacrificed at E18.5. Tbr1 immunostaining and DAPI-labeled sections (25 mm) were used to draw contours in Neurolucida of CP including subplate. A blinded observer quantified GFP + cells by placing and scaling a grid evenly divided into six bins over the electroporated region that spanned the layer 1/2 boundary (upper) and subplate (deeper). Distributions of cells were compared using ANOVA (Repeated Measures).
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